Literature DB >> 18587272

Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.

Pil-Gu Park1, Hyunsook Lee.   

Abstract

Germ-line mutations in BRCA2 predispose to early-onset cancer. Homozygous mutant mouse, which has Brca2 truncated in exon 11 exhibit paradoxic occurrence of growth retardation and development of thymic lymphomas. However, due to its large embryonic lethality, cohort studies on the thymic lymphomas were not feasible. With the aid of Cre-loxP system, we demonstrate here that thymus-specific disruption of Brca2 allele without crossing it to p53-mutant background leads to the development of thymic lymphomas. Varying from 16 weeks to 66 weeks after birth, 25% of mice disrupted of Brca2 in the thymus died of thymic lymphomas, whereas previous report did not observe lymphomagenesis using similar Cre-loxP system. Future analysis of thymic lymphomas from these mice presented here will provide information on the cooperative mutations that are required for the BRCA2-associated pathogenesis of cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587272      PMCID: PMC2679290          DOI: 10.3858/emm.2008.40.3.339

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  21 in total

1.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein.

Authors:  A A Davies; J Y Masson; M J McIlwraith; A Z Stasiak; A Stasiak; A R Venkitaraman; S C West
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 2.  A growing network of cancer-susceptibility genes.

Authors:  Ashok R Venkitaraman
Journal:  N Engl J Med       Date:  2003-05-08       Impact factor: 91.245

Review 3.  Tracing the network connecting BRCA and Fanconi anaemia proteins.

Authors:  Ashok R Venkitaraman
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

4.  Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.

Authors:  Alison M Y Cheung; M Prakash Hande; Farid Jalali; Ming-Sound Tsao; Brian Skinnider; Atsushi Hirao; J Peter McPherson; Jana Karaskova; Akira Suzuki; Andrew Wakeham; Annick You-Ten; Andrew Elia; Jeremy Squire; Rob Bristow; Razqallah Hakem; Tak W Mak
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

5.  BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.

Authors:  Haijuan Yang; Philip D Jeffrey; Julie Miller; Elspeth Kinnucan; Yutong Sun; Nicolas H Thoma; Ning Zheng; Phang-Lang Chen; Wen-Hwa Lee; Nikola P Pavletich
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

6.  Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte.

Authors:  Craig D Woodworth; Evan Michael; Laura Smith; Kinnimulki Vijayachandra; Adam Glick; Henry Hennings; Stuart H Yuspa
Journal:  Carcinogenesis       Date:  2004-04-22       Impact factor: 4.944

7.  Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.

Authors:  Luca Pellegrini; David S Yu; Thomas Lo; Shubha Anand; MiYoung Lee; Tom L Blundell; Ashok R Venkitaraman
Journal:  Nature       Date:  2002-11-10       Impact factor: 49.962

8.  Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.

Authors:  Matthew J Daniels; Yunmei Wang; Miyoung Lee; Ashok R Venkitaraman
Journal:  Science       Date:  2004-09-16       Impact factor: 47.728

9.  Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.

Authors:  Owen Richard Davies; Luca Pellegrini
Journal:  Nat Struct Mol Biol       Date:  2007-06       Impact factor: 15.369

10.  Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.

Authors:  Hyunsook Lee
Journal:  Exp Mol Med       Date:  2003-10-31       Impact factor: 8.718

View more
  2 in total

1.  Transgenic and knockout mice models to reveal the functions of tumor suppressor genes.

Authors:  Pankaj Taneja; Sinan Zhu; Dejan Maglic; Elizabeth A Fry; Robert D Kendig; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2011-07-28

2.  Brca2 deficiency leads to T cell loss and immune dysfunction.

Authors:  Jun-Hyeon Jeong; Areum Jo; Pilgu Park; Hyunsook Lee; Hae-Ock Lee
Journal:  Mol Cells       Date:  2015-02-04       Impact factor: 5.034

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.